Phase III confirmatory study on a cancer pain treatment drug, HFT 290 (a once-a-day application fentanyl citrate transdermal system)
Latest Information Update: 19 Mar 2013
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Registrational; Therapeutic Use
- 19 Mar 2013 New trial record